Valenzuela HF - Search Results

1

Functional assessment of pharmacological telomerase activators in human T cells.

Molgora B, Bateman R, Sweeney G, Finger D, Dimler T, Effros RB, Valenzuela HF. Molgora B, et al. Among authors: valenzuela hf. Cells. 2013 Jan 14;2(1):57-66. doi: 10.3390/cells2010057. Cells. 2013. PMID: 24709644 Free PMC article.

2

Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus.

Valenzuela HF, Effros RB. Valenzuela HF, et al. Clin Immunol. 2002 Nov;105(2):117-25. doi: 10.1006/clim.2002.5271. Clin Immunol. 2002. PMID: 12482386

3

In vitro senescence of immune cells.

Effros RB, Dagarag M, Valenzuela HF. Effros RB, et al. Among authors: valenzuela hf. Exp Gerontol. 2003 Nov-Dec;38(11-12):1243-9. doi: 10.1016/j.exger.2003.09.004. Exp Gerontol. 2003. PMID: 14698803 Review.

4

Telomeres and replicative senescence.

Valenzuela HF, Effros RB. Valenzuela HF, et al. Methods Mol Med. 2000;38:63-70. doi: 10.1385/1-59259-070-5:63. Methods Mol Med. 2000. PMID: 22351265

5

Telomere shortening in T cells correlates with Alzheimer's disease status.

Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, Cummings JL, Effros RB. Panossian LA, et al. Among authors: valenzuela hf. Neurobiol Aging. 2003 Jan-Feb;24(1):77-84. doi: 10.1016/s0197-4580(02)00043-x. Neurobiol Aging. 2003. PMID: 12493553

6

O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.

Valenzuela HF, Pace KE, Cabrera PV, White R, Porvari K, Kaija H, Vihko P, Baum LG. Valenzuela HF, et al. Cancer Res. 2007 Jul 1;67(13):6155-62. doi: 10.1158/0008-5472.CAN-05-4431. Cancer Res. 2007. PMID: 17616672

7

Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in the diagnosis of bone metastasis in prostate cancer.

Lorente JA, Morote J, Raventos C, Encabo G, Valenzuela H. Lorente JA, et al. J Urol. 1996 Apr;155(4):1348-51. J Urol. 1996. PMID: 8632571 Clinical Trial.

8

Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients.

Lorente JA, Valenzuela H, Morote J, Gelabert A. Lorente JA, et al. Eur J Nucl Med. 1999 Jun;26(6):625-32. doi: 10.1007/s002590050430. Eur J Nucl Med. 1999. PMID: 10369948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page